Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and OEM. The Advanced Energy segment's product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It is focused on the cosmetic surgery market where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue to achieve their desired results. Its product lines consist of a multifunction generator, a handpiece and a supply of helium gas. The OEM segment leverages its expertise in the design, development and manufacturing of electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers through original equipment manufacturing agreements, as well as start-up companies with the need for its energy-based designs.
BörsenkürzelAPYX
Name des UnternehmensApyx Medical Corp
IPO-datumJul 22, 1983
CEOMr. Charles D. Goodwin, II
Anzahl der mitarbeiter220
WertpapierartOrdinary Share
GeschäftsjahresendeJul 22
Addresse5115 Ulmerton Rd
StadtCLEARWATER
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl33760-4004
Telefon18005372790
Websitehttps://apyxmedical.com/
BörsenkürzelAPYX
IPO-datumJul 22, 1983
CEOMr. Charles D. Goodwin, II
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten